Gene: SV2C
Official Full Name: synaptic vesicle glycoprotein 2Cprovided by HGNC
Gene Summary: Predicted to enable transmembrane transporter activity. Predicted to be involved in several processes, including chemical synaptic transmission; neurotransmitter transport; and regulation of synaptic vesicle exocytosis. Predicted to be located in plasma membrane and synaptic vesicle. Predicted to be active in dopaminergic synapse and synaptic vesicle membrane. [provided by Alliance of Genome Resources, Apr 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA10914 | SV2C Knockout cell line (AC16) | Human | SV2C | 1:3-1:4 | negative | Online Inquiry |
| KOA26359 | SV2C Knockout cell line (BEAS-2B) | Human | SV2C | 1:3~1:4 | negative | Online Inquiry |
| KOA41797 | SV2C Knockout cell line (U-2932) | Human | SV2C | 1:2-1:4 | negative | Online Inquiry |
| KOA57175 | SV2C Knockout cell line (TPC-1) | Human | SV2C | 1:5-1:8 | negative | Online Inquiry |
| KOA72604 | SV2C Knockout cell line (NCM460) | Human | SV2C | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.